Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Inventory Average for 8 consecutive years, with $34.0 million as the latest value for Q1 2026.

  • For Q1 2026, Inventory Average rose 18.85% year-over-year to $34.0 million; the TTM value through Mar 2026 reached $34.0 million, up 18.85%, while the annual FY2025 figure was $30.3 million, 29.65% up from the prior year.
  • Inventory Average hit $34.0 million in Q1 2026 for Agios Pharmaceuticals, up from $32.5 million in the prior quarter.
  • Across five years, Inventory Average topped out at $34.0 million in Q1 2026 and bottomed at $3.3 million in Q2 2022.
  • Average Inventory Average over 5 years is $20.4 million, with a median of $22.3 million recorded in 2024.
  • Year-over-year, Inventory Average skyrocketed 313.22% in 2023 and then grew 18.85% in 2026.
  • Agios Pharmaceuticals' Inventory Average stood at $6.8 million in 2022, then skyrocketed by 165.95% to $18.2 million in 2023, then soared by 48.68% to $27.0 million in 2024, then rose by 20.19% to $32.5 million in 2025, then increased by 4.7% to $34.0 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods came in at $34.0 million, $32.5 million, and $31.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.